Literature DB >> 21271650

Identification of a novel C16orf57 mutation in Athabaskan patients with Poikiloderma with Neutropenia.

Carol Clericuzio1, Karine Harutyunyan, Weidong Jin, Robert P Erickson, Alan D Irvine, W H Irwin McLean, Yaran Wen, Rochelle Bagatell, Thomas A Griffin, Tor A Shwayder, Sharon E Plon, Lisa L Wang.   

Abstract

Poikiloderma with Neutropenia (PN), Clericuzio-Type (OMIM #604173) is characterized by poikiloderma, chronic neutropenia, recurrent sinopulmonary infections, bronchiectasis, and nail dystrophy. First described by Clericuzio in 1991 in 14 patients of Navajo descent, it has since also been described in non-Navajo patients. C16orf57 has recently been identified as a causative gene in PN. The purpose of our study was to describe a spectrum of C16orf57 mutations in a cohort of PN patients including five patients of Athabaskan (Navajo and Apache) ancestry. Eleven patients from eight kindreds were enrolled in an IRB-approved study at Baylor College of Medicine. Five patients were of Athabaskan ancestry. PCR amplification and sequencing of the entire coding region of the C16orf57 gene was performed on genomic DNA. We identified biallelic C16orf57 mutations in all 11 PN patients in our cohort. The seven new deleterious mutations consisted of deletion (2), nonsense (3), and splice site (2) mutations. The patients of Athabaskan ancestry all had a common deletion mutation (c.496delA) which was not found in the six non-Athabaskan patients. Mutations in the C16orf57 gene have been identified thus far in all patients studied with a clinical diagnosis of PN. We have identified seven new mutations in C16orf57 in PN patients. One of these is present in all patients of Athabaskan descent, suggesting that c.496delA represents the PN-causative mutation in this subpopulation.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21271650      PMCID: PMC3069503          DOI: 10.1002/ajmg.a.33807

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  15 in total

1.  Absence of RECQL4 mutations in poikiloderma with neutropenia in Navajo and non-Navajo patients.

Authors:  Lisa L Wang; Anu Gannavarapu; Carol L Clericuzio; Robert P Erickson; Alan D Irvine; Sharon E Plon
Journal:  Am J Med Genet A       Date:  2003-04-30       Impact factor: 2.802

2.  Rothmund-Thomson syndrome with myelodysplasia.

Authors:  S Narayan; C Fleming; A H Trainer; J A Craig
Journal:  Pediatr Dermatol       Date:  2001 May-Jun       Impact factor: 1.588

3.  Myelodysplastic syndrome in a child with Rothmund-Thomson syndrome: a case report.

Authors:  C Rizzari; D Bacchiocchi; A Rovelli; A Biondi; A Cantu'-Rajnoldi; C Uderzo; G Masera
Journal:  J Pediatr Hematol Oncol       Date:  1996-02       Impact factor: 1.289

4.  Rothmund-Thomson syndrome (Thomson-type) and myelodysplasia.

Authors:  E Pianigiani; G De Aloe; A Andreassi; P Rubegni; M Fimiani
Journal:  Pediatr Dermatol       Date:  2001 Sep-Oct       Impact factor: 1.588

5.  Aplastic anemia in a patient with Rothmund-Thomson syndrome.

Authors:  K A Knoell; N K Sidhu-Malik; R K Malik
Journal:  J Pediatr Hematol Oncol       Date:  1999 Sep-Oct       Impact factor: 1.289

6.  Haematological disease in siblings with Rothmund-Thomson syndrome.

Authors:  W M Porter; C M Hardman; S H Abdalla; A V Powles
Journal:  Clin Exp Dermatol       Date:  1999-11       Impact factor: 3.470

7.  Clericuzio type poikiloderma with neutropenia is distinct from Rothmund-Thomson syndrome.

Authors:  Johan L K Van Hove; Jaak Jaeken; Marijke Proesmans; Kris De Boeck; Kristin Minner; Gert Matthijs; Eric Verbeken; Anouk Demunter; Marc Boogaerts
Journal:  Am J Med Genet A       Date:  2005-01-15       Impact factor: 2.802

8.  Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thomson syndrome.

Authors:  Lisa L Wang; Anu Gannavarapu; Claudia A Kozinetz; Moise L Levy; Richard A Lewis; Murali M Chintagumpala; Ramon Ruiz-Maldanado; Jose Contreras-Ruiz; Christopher Cunniff; Robert P Erickson; Dorit Lev; Maureen Rogers; Elaine H Zackai; Sharon E Plon
Journal:  J Natl Cancer Inst       Date:  2003-05-07       Impact factor: 13.506

9.  Mutations in C16orf57 and normal-length telomeres unify a subset of patients with dyskeratosis congenita, poikiloderma with neutropenia and Rothmund-Thomson syndrome.

Authors:  Amanda J Walne; Tom Vulliamy; Richard Beswick; Michael Kirwan; Inderjeet Dokal
Journal:  Hum Mol Genet       Date:  2010-09-03       Impact factor: 6.150

10.  Poikiloderma with neutropenia, Clericuzio type, in a family from Morocco.

Authors:  Rahima Mostefai; Fanny Morice-Picard; Franck Boralevi; Michel Sautarel; Didier Lacombe; Marie José Stasia; John McGrath; Alain Taïeb
Journal:  Am J Med Genet A       Date:  2008-11-01       Impact factor: 2.802

View more
  11 in total

Review 1.  The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches.

Authors:  Elisabeth Daguenet; Gwendal Dujardin; Juan Valcárcel
Journal:  EMBO Rep       Date:  2015-11-13       Impact factor: 8.807

2.  Incomplete splicing of neutrophil-specific genes affects neutrophil development in a zebrafish model of poikiloderma with neutropenia.

Authors:  Prakash Patil; Tamayo Uechi; Naoya Kenmochi
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

3.  Clinical utility gene card for: poikiloderma with neutropenia.

Authors:  Lidia Larizza; Gloria Negri; Elisa Adele Colombo; Ludovica Volpi; Yves Sznajer
Journal:  Eur J Hum Genet       Date:  2013-01-16       Impact factor: 4.246

4.  C16orf57, a gene mutated in poikiloderma with neutropenia, encodes a putative phosphodiesterase responsible for the U6 snRNA 3' end modification.

Authors:  Seweryn Mroczek; Joanna Krwawicz; Jan Kutner; Michal Lazniewski; Iwo Kuciński; Krzysztof Ginalski; Andrzej Dziembowski
Journal:  Genes Dev       Date:  2012-08-16       Impact factor: 11.361

5.  Insights into Mutation Effect in Three Poikiloderma with Neutropenia Patients by Transcript Analysis and Disease Evolution of Reported Patients with the Same Pathogenic Variants.

Authors:  Elisa A Colombo; Nursel H Elcioglu; Claudio Graziano; Pamela Farinelli; Elisabetta Di Fede; Iria Neri; Elena Facchini; Mariangela Greco; Cristina Gervasini; Lidia Larizza
Journal:  J Clin Immunol       Date:  2018-05-16       Impact factor: 8.317

Review 6.  Weaving the Strands of Life (Iiná Bitł'ool): History of Genetic Research Involving Navajo People.

Authors:  Rene L Begay; Nanibaa' A Garrison; Franklin Sage; Mark Bauer; Ursula Knoki-Wilson; David H Begay; Beverly Becenti-Pigman; Katrina G Claw
Journal:  Hum Biol       Date:  2020-07-09       Impact factor: 0.553

7.  Novel C16orf57 mutations in patients with Poikiloderma with Neutropenia: bioinformatic analysis of the protein and predicted effects of all reported mutations.

Authors:  Elisa A Colombo; J Fernando Bazan; Gloria Negri; Cristina Gervasini; Nursel H Elcioglu; Deniz Yucelten; Ilknur Altunay; Umram Cetincelik; Anna Teti; Andrea Del Fattore; Matteo Luciani; Spencer K Sullivan; Albert C Yan; Ludovica Volpi; Lidia Larizza
Journal:  Orphanet J Rare Dis       Date:  2012-01-23       Impact factor: 4.123

8.  Marked overlap of four genetic syndromes with dyskeratosis congenita confounds clinical diagnosis.

Authors:  Amanda J Walne; Laura Collopy; Shirleny Cardoso; Alicia Ellison; Vincent Plagnol; Canan Albayrak; Davut Albayrak; Sara Sebnem Kilic; Turkan Patıroglu; Haluk Akar; Keith Godfrey; Tina Carter; Makia Marafie; Ajay Vora; Mikael Sundin; Thomas Vulliamy; Hemanth Tummala; Inderjeet Dokal
Journal:  Haematologica       Date:  2016-09-09       Impact factor: 9.941

9.  Poikiloderma With Neutropenia and Mastocytosis: A Case Report and a Review of Dermatological Signs.

Authors:  Vincenzo Piccolo; Teresa Russo; Daniela Di Pinto; Elvira Pota; Martina Di Martino; Giulio Piluso; Andrea Ronchi; Giuseppe Argenziano; Eugenia Veronica Di Brizzi; Claudia Santoro
Journal:  Front Med (Lausanne)       Date:  2021-06-10

10.  A zebrafish model of Poikiloderma with Neutropenia recapitulates the human syndrome hallmarks and traces back neutropenia to the myeloid progenitor.

Authors:  Elisa A Colombo; Silvia Carra; Laura Fontana; Erica Bresciani; Franco Cotelli; Lidia Larizza
Journal:  Sci Rep       Date:  2015-11-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.